"VITALINK’S FULLY INTEGRATED NETWORK OF CLINICAL TRIALS SITES connects renowned physicians and medical professionals with site managers and coordinators to create a seamless trial experience that puts the patient first and produces trustworthy and consistent results"

During the past decade, Vitalink Research-Spartanburg conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vitalink Research-Spartanburg" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Verona Pharma plc" with 2 trials sponsored, "Clear Creek Bio, Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vitalink Research-Spartanburg" #1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "LGC Limited" with 1 trials as a collaborator and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Vitalink Research-Spartanburg" are "Pulmonary Disease, Chronic Obstructive" (2 trials), "COPD" (1 trials), "COVID-19" (1 trials), "COVID-19 Infection" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Vitalink Research-Spartanburg" in a lesser frequency.

Most popular intervention types in "Vitalink Research-Spartanburg" are "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Acthar Gel" (1 trials), "Ad26.RSV.preF-based vaccine" (1 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials) and "Aspirin (ASA) Oral Tablet - Pre-Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vitalink Research-Spartanburg" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Vitalink Research-Spartanburg". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Vitalink Research-Spartanburg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vitalink Research-Spartanburg, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".